An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.
|Videos|August 11, 2016
Halle Moore on Fatigue in Breast Cancer Survivors
Author(s)Halle Moore
Halle Moore, medical oncologist at the Cleveland Clinic, discusses fatigue in breast cancer survivors.
Advertisement
Halle Moore, medical oncologist at the Cleveland Clinic, discusses fatigue in breast cancer survivors.
In a study of breast cancer survivors at the Cleveland Clinic, Moore found that fatigue was a common symptom that increased with age, but decreased as patients were further out of their treatment.
Advertisement
Related to this article
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
Joy Maulik, MSN, FNP-C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean on education, their providers and caregivers.
Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, recurrence and life after treatment begins.
Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, kidney cancer, colorectal cancer and stomach and esophageal cancer kept helping patients years later.
Dr. Jacqueline Barrientos shares how a targeted therapy, a determined care team and a stranger’s generosity gave a 72-year-old man with hairy cell leukemia and kidney failure a second chance.
Two phase 3 trials at ESMO 2026 brought new options for advanced endometrial cancer, and final results for Verzenio after another CDK4/6 drug showed a survival difference that was not statistically significant.
Dr. Robert Kreitman explains how CD22-targeted CAR T could help heavily pretreated patients.
Advertisement
Advertisement
Trending on CURE
1
Medicare to Cut Ostomy Suppliers to 8 Contracts: What Patients Need to Know
2
3 ESMO 2026 Results in Endometrial and Breast Cancer to Know
3
3 Quality-of-Life Results From ESMO 2026 Patients Should Know
4
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
5